Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mechanisms of Ikaros Tumor Suppression with HDAC1 through distinct histone markers in Pre-B ALL Leukemia

ABSTRACT: Ikaros functions as a master regulator of lymphocyte differentiation and a tumor suppressor. Ikaros binds DNA and regulates gene expression by chromatin remodeling. Mechanisms of Ikaros-mediated tumor suppression are unknown. Here we examined genome-wide occupancy of Ikaros and histone deacetylase 1 (HDAC1) and Histone midificaition markers in human leukemia, and found that the Ikaros and HDAC1 showed similar binding partern and HDAC1–DNA interactions are associated with the presence of bivalent chromatin, and the recruitment of HDAC1 by Ikaros is associated with bivalent chromatin at Ikaros target genes.

ORGANISM(S): Homo sapiens

PROVIDER: GSE44217 | GEO | 2015/11/03

SECONDARY ACCESSION(S): PRJNA189195

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Mechanisms of Ikaros Tumor Suppression with HDAC1 through distinct histone markers in Pre-B ALL Leukemia

Project description:Ikaros functions as a master regulator of lymphocyte differentiation and a tumor suppressor. Ikaros binds DNA and regulates gene expression by chromatin remodeling. Mechanisms of Ikaros-mediated tumor suppression are unknown. Here we examined genome-wide occupancy of Ikaros and histone deacetylase 1 (HDAC1) and Histone midificaition markers in human leukemia, and found that the Ikaros and HDAC1 showed similar binding partern and HDAC1âDNA interactions are associated with the presence of bivalent chromatin, and the recruitment of HDAC1 by Ikaros is associated with bivalent chromatin at Ikaros target genes. Examine the genome-wide binding of Ikaros, HDAC1, H3K9me3, H3K9ac, H3K27me3, H3K4me3 and H3K36me3 in Nalm6 ALL leukemia cells.

2015-11-03 | E-GEOD-44217 | biostudies-arrayexpress

Ikaros tumor suppression and epigenetic regulation [ATAC-seq]

Project description:Ikaros encodes a transcription factor that functions as a tumor suppressor in T-ALL. The mechanisms through which Ikaros regulates gene expression and cellular proliferation in T-ALL are unknown. Re-introduction of Ikaros into Ikaros-null T-ALL cells results in cessation of cellular proliferation and induction of T-cell differentiation. We performed dynamic global epigenomic and gene expression analyses to determine the role of Ikaros in tumor suppression during this process. Our results identified novel Ikaros functions in the epigenetic regulation of gene expression: Ikaros directly regulates de novo formation and depletion of enhancers, as well as de novo formation of active enhancers and activation of poised enhancers; Ikaros directly induces the formation of super-enhancers; and Ikaros demonstrates pioneering activity by directly regulating chromatin accessibility. Dynamic analyses demonstrate the long-lasting effect of Ikaros DNA binding on enhancer activation, de novo formation of enhancers and super-enhancers, and chromatin accessibility. Ikaros induces profound, global re-distribution of HDAC1 via recruitment of HDAC1 to promoter and enhancer regions of different target genes. Expression analysis identified a large number of novel signaling pathways that are directly regulated by Ikaros and Ikaros-induced enhancers, and that are responsible for the cessation of proliferation and induction of T-cell differentiation in T-ALL cells.

2019-03-31 | GSE126567 | GEO

Ikaros tumor suppression and epigenetic regulation [gene expression]

2019-03-31 | GSE126391 | GEO

Ikaros tumor suppression and epigenetic regulation [ChIP-seq]

2019-03-31 | GSE126568 | GEO

Ikaros tumor suppression and epigenetic regulation

Project description:Ikaros tumor suppression and epigenetic regulation

| PRJNA522391 | ENA

Mechanism of Ikaros tumor suppression in Leukemia

Project description:Mechanism of Ikaros tumor suppression in Leukemia

| PRJNA189192 | ENA

Transcription profiling of mouse hematopoietic cells, Ikaros wt and null mutant

Project description:Regulation of lineage potential and transcriptional priming by Ikaros. New insight is provided into a bivalent regulation of lineage priming in the HSC and its lympho-myeloid restricted progeny the LMPP by the lymphoid lineage-determining factor Ikaros; Whereas Ikaros is responsible for the activation of a cascade of lymphoid expression programs and for the establishment of lymphoid potential from the HSC to the LMPP it is also responsible for the repression of stem cell and erythroid genetic programs that are incompatible with further lineage restrictions emanating from the LMPP Experiment Overall Design: Ikaros null versus wt

2009-04-11 | E-GEOD-15330 | biostudies-arrayexpress

Ikaros tumor suppression and epigenetic regulation [ChIP-seq]

Project description:Ikaros tumor suppression and epigenetic regulation [ChIP-seq]

| PRJNA522415 | ENA

Ikaros tumor suppression and epigenetic regulation [ATAC-seq]

Project description:Ikaros tumor suppression and epigenetic regulation [ATAC-seq]

| PRJNA522416 | ENA

Ikaros tumor suppression and epigenetic regulation [gene expression]

Project description:Ikaros tumor suppression and epigenetic regulation [gene expression]

| PRJNA521762 | ENA